Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: A proteomic approach

Clinical Immunology

Volumn 153, Issue 1, 2014, Pages 123-135

  Régent, Alexis ^a,b   Lofek, Sébastien ^a   Dib, Hanadi ^a   Bussone, Guillaume ^b   Tamas, Nicolas ^a   Federici, Christian ^a,c   Broussard, Cédric ^a,c   Guillevin, Loïc ^a,b   Mouthon, Luc ^a,b  

^a INSTITUT COCHIN   (France)

^b Centre National de Reference Pour Les Vascularites Systemiques et la Sclerodermie Systemique   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anti neutrophil cytoplasmic antibodies; Autoantibodies; Erk; Human umbilical vein endothelial cell; Lamin; Vasculitides

Indexed keywords

ALPHA ENOLASE; AUTOANTIGEN; ENDOTHELIAL CELL ANTIBODY; FAR UPSTREAM BINDING PROTEIN 2; IMMUNOGLOBULIN G; LAMIN A; LAMIN C; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHODIESTERASE A3; PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; TWO DIMENSIONAL ELECTROPHORESIS; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES; AUTOANTIBODIES; ERK; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL; LAMIN; VASCULITIDES;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; AUTOANTIGENS; AUTOIMMUNE DISEASES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOGLOBULIN G; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN INTERACTION MAPS; PROTEOMICS; SIGNAL TRANSDUCTION; VASCULITIS;

EID: 84899830555     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.03.020     Document Type: Article

References (35)

1. Mahr A., Katsahian S., Varet H., Guillevin L., Hagen E.C., Hoglund P., Merkel P.A., Pagnoux C., Rasmussen N., Westman K., Jayne D.R. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann. Rheum. Dis. 2013, 72:1003-1010.
2. Witko-Sarsat V., Daniel S., Noel L.H., Mouthon L. Neutrophils and B lymphocytes in ANCA-associated vasculitis. APMIS Suppl. 2009, 27-31.
3. Mouthon L., Millet A., Regent A., Pederzoli-Ribeil M., Witko-Sarsat V. Pathophysiology of ANCA-associated vasculitides. Presse Med. 2012, 41:996-1003.
4. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., Kallenberg C.G., St Clair E.W., Turkiewicz A., Tchao N.K., Webber L., Ding L., Sejismundo L.P., Mieras K., Weitzenkamp D., Ikle D., Seyfert-Margolis V., Mueller M., Brunetta P., Allen N.B., Fervenza F.C., Geetha D., Keogh K.A., Kissin E.Y., Monach P.A., Peikert T., Stegeman C., Ytterberg S.R., Specks U. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 2010, 363:221-232.
5. Jones R.B., Tervaert J.W., Hauser T., Luqmani R., Morgan M.D., Peh C.A., Savage C.O., Segelmark M., Tesar V., van Paassen P., Walsh D., Walsh M., Westman K., Jayne D.R. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N. Engl. J. Med. 2010, 363:211-220.
6. Carvalho D., Savage C.O., Isenberg D., Pearson J.D. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum. 1999, 42:631-640.
7. Dib H., Tamby M.C., Bussone G., Regent A., Berezne A., Lafine C., Broussard C., Simonneau G., Guillevin L., Witko-Sarsat V., Humbert M., Mouthon L. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur. Respir. J. 2012, 39:1405-14.
8. Del Papa N., Guidali L., Sironi M., Shoenfeld Y., Mantovani A., Tincani A., Balestrieri G., Radice A., Sinico R.A., Meroni P.L. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum. 1996, 39:758-766.
9. Holmen C., Elsheikh E., Christensson M., Liu J., Johansson A.S., Qureshi A.R., Jalkanen S., Sumitran-Holgersson S. Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis. J. Am. Soc. Nephrol. 2007, 18:2497-2508.
10. Savage C.O., Pottinger B.E., Gaskin G., Lockwood C.M., Pusey C.D., Pearson J.D. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin. Exp. Immunol. 1991, 85:14-19.
11. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37:187-192.
12. Luqmani R.A., Bacon P.A., Moots R.J., Janssen B.A., Pall A., Emery P., Savage C., Adu D. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 1994, 87:671-678.
13. Tamby M.C., Chanseaud Y., Humbert M., Fermanian J., Guilpain P., Garcia-de-la-Pena-Lefebvre P., Brunet S., Servettaz A., Weill B., Simonneau G., Guillevin L., Boissier M.C., Mouthon L. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005, 60:765-772.
14. Dib H., Chafey P., Clary G., Federici C., Le Gall M., Dwyer J., Gavard J., Tamas N., Bussone G., Broussard C., Camoin L., Witko-Sarsat V., Tamby M.C., Mouthon L. Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition. Proteomics 2012, 12:2547-2555.
15. Regent A., Dib H., Ly K.H., Agard C., Tamby M.C., Tamas N., Weksler B., Federici C., Broussard C., Guillevin L., Mouthon L. Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. Arthritis Res. Ther. 2011, 13:R107.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
17. Bussone G., Dib H., Dimitrov J.D., Camoin L., Broussard C., Tamas N., Guillevin L., Kaveri S.V., Mouthon L. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations. Proteomics 2009, 9:2253-2262.
18. Bussone G., Tamby M.C., Calzas C., Kherbeck N., Sahbatou Y., Sanson C., Ghazal K., Dib H., Weksler B.B., Broussard C., Verrecchia F., Yaici A., Witko-Sarsat V., Simonneau G., Guillevin L., Humbert M., Mouthon L. IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction. Ann. Rheum. Dis. 2012, 71:596-605.
19. Millet A., Pederzoli-Ribeil M., Guillevin L., Witko-Sarsat V., Mouthon L. Anti-neutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?. Ann. Rheum. Dis. 2013, 72:1273-9.
20. Navarro M., Cervera R., Font J., Reverter J.C., Monteagudo J., Escolar G., Lopez-Soto A., Ordinas A., Ingelmo M. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997, 6:521-526.
21. Chanseaud Y., Garcia de la Pena-Lefebvre P., Guilpain P., Mahr A., Tamby M.C., Uzan M., Guillevin L., Boissier M.C., Mouthon L. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin. Immunol. 2003, 109:165-178.
22. Del Papa N., Conforti G., Gambini D., La Rosa L., Tincani A., D'cruz D., Khamashta M., Hughes G.R., Balestrieri G., Meroni P.L. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin. Immunol. Immunopathol. 1994, 70:211-216.
23. Kaneko M., Ono T., Matsubara T., Yamamoto Y., Ikeda H., Yoshiki T., Furukawa S., Nakayama E. Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbiol. Immunol. 2004, 48:703-711.
24. Lee K.H., Chung H.S., Kim H.S., Oh S.H., Ha M.K., Baik J.H., Lee S., Bang D. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum. 2003, 48:2025-2035.
25. Mayet W.J., Schwarting A., Meyer zum Buschenfelde K.H. Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin. Exp. Immunol. 1994, 97:458-465.
26. Karasawa R., Kurokawa M.S., Yudoh K., Masuko K., Ozaki S., Kato T. Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin. Exp. Immunol. 2010, 161:459-470.
27. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., Dutra A., Pak E., Durkin S., Csoka A.B., Boehnke M., Glover T.W., Collins F.S. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298.
28. Bussone G., Dib H., Tamby M.C., Broussard C., Federici C., Woimant G., Camoin L., Guillevin L., Mouthon L. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis. Arthritis Res. Ther. 2011, 13:R74.
29. de la Salle H., Hanau D., Fricker D., Urlacher A., Kelly A., Salamero J., Powis S.H., Donato L., Bausinger H., Laforet M., et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994, 265:237-241.
30. Villa-Forte A., de la Salle H., Fricker D., Hentges F., Zimmer J. HLA class I deficiency syndrome mimicking Wegener's granulomatosis. Arthritis Rheum. 2008, 58:2579-2582.
31. Shimizu C., Jain S., Davila S., Hibberd M.L., Lin K.O., Molkara D., Frazer J.R., Sun S., Baker A.L., Newburger J.W., Rowley A.H., Shulman S.T., Burgner D., Breunis W.B., Kuijpers T.W., Wright V.J., Levin M., Eleftherohorinou H., Coin L., Popper S.J., Relman D.A., Fury W., Lin C., Mellis S., Tremoulet A.H., Burns J.C. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ. Cardiovasc. Genet. 2011, 4:16-25.
32. Loeys B.L., Chen J., Neptune E.R., Judge D.P., Podowski M., Holm T., Meyers J., Leitch C.C., Katsanis N., Sharifi N., Xu F.L., Myers L.A., Spevak P.J., Cameron D.E., De Backer J., Hellemans J., Chen Y., Davis E.C., Webb C.L., Kress W., Coucke P., Rifkin D.B., De Paepe A.M., Dietz H.C. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 2005, 37:275-281.
33. Lee K.H., Cho H.J., Kim H.S., Lee W.J., Lee S., Bang D. Activation of extracellular signal regulated kinase 1/2 in human dermal microvascular endothelial cells stimulated by anti-endothelial cell antibodies in sera of patients with Behcet's disease. J. Dermatol. Sci. 2002, 30:63-72.
34. Haubitz M., Dhaygude A., Woywodt A. Mechanisms and markers of vascular damage in ANCA-associated vasculitis. Autoimmunity 2009, 42:605-614.
35. Jamin C., Dugue C., Alard J.E., Jousse S., Saraux A., Guillevin L., Piette J.C., Youinou P. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum. 2005, 52:4028-4038.